Navamedic ASA: Navamedic launches new generic drug

              Navamedic ASA: Navamedic launches new generic drug

Navamedic ASA (OSE: NAVA), the Norwegian pharmaceutical products company,
today announced the launch of a new generic pharmaceutical product. The new
generic can replace Viagra and is Navamedic's 15^th product launch so far this

The product now being launched is Sildenafil Aspen, which is used by men
suffering from erectile dysfunction. The generic drug can replace Pfizer's
Viagra. The product will be introduced across all Navamedic's key markets in
the Nordic, except Norway.

Navamedic has been developing its portfolio of generic drugs since 2011 and is
aiming to become a significant provider of generic drugs in the Nordic and
Benelux markets. The cooperation with Aspen of South Africa, one of the
world's largest manufacturers of generic pharmaceuticals, is a cornerstone of
this strategy. The cooperation is proving successful, providing Navamedic with
an attractive pipeline of new products.

For further information, please call Håkan Josephsson, CEO, telephone +46 706
742533 or Bjørn Lindholt, CFO, telephone +47 9300 6601.

Navamedic ASA is a Norwegian pharmaceutical products company, marketing and
distributing more than 100 products in the Nordic and Benelux markets. The
Company operates three business areas; Pharma Products, Medical Nutrition and
Consumer Care based on its relationship with a number of pharmaceutical
product manufacturers. Navamedic is listed on the Oslo Stock Exchange (ticker:


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Navamedic ASA via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.